These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
914 related items for PubMed ID: 8027577
41. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome. Whittaker SJ, Smith NP, Jones RR, Luzzatto L. Cancer; 1991 Oct 01; 68(7):1572-82. PubMed ID: 1654197 [Abstract] [Full Text] [Related]
42. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications. Hsi AC, Lee SJ, Rosman IS, Carson KR, Kelley A, Viele V, Pang X, Musiek A, Schaffer A. J Am Acad Dermatol; 2015 Jan 01; 72(1):159-67. PubMed ID: 25440432 [Abstract] [Full Text] [Related]
43. Cytokine profile of tumor cells in mycosis fungoides: successful treatment with intra-lesional interferon-gamma combined with chemotherapy. Yamamoto T, Sasaki G, Sato T, Katayama I, Nishioka K. J Dermatol; 1995 Sep 01; 22(9):650-4. PubMed ID: 8537550 [Abstract] [Full Text] [Related]
44. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Jarrousse V, Quereux G, Marques-Briand S, Knol AC, Khammari A, Dreno B. Eur J Dermatol; 2006 Sep 01; 16(6):636-41. PubMed ID: 17229603 [Abstract] [Full Text] [Related]
45. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Delfau-Larue MH, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M, Bagot M, Farcet JP. Blood; 2000 Nov 01; 96(9):2987-92. PubMed ID: 11049975 [Abstract] [Full Text] [Related]
46. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. Paschke R, Schuppert F, Taton M, Velu T. J Endocrinol; 1994 May 01; 141(2):309-15. PubMed ID: 8046301 [Abstract] [Full Text] [Related]
47. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Jothishankar B, Venkataraman G, Goldberg RC, Abdulla F. Ann Diagn Pathol; 2019 Dec 01; 43():151404. PubMed ID: 31629155 [No Abstract] [Full Text] [Related]
48. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification. Horna P, Moscinski LC, Sokol L, Shao H. Cytometry B Clin Cytom; 2019 May 01; 96(3):234-241. PubMed ID: 30328260 [Abstract] [Full Text] [Related]
49. Alteration of cytokine genes and bcl-2 expression following immunotherapy with intralesional IFN-gamma in a patient with tumor-stage mycosis fungoides. Yamamoto T, Takahashi Y, Katayama I, Nishioka K. Dermatology; 1998 May 01; 196(3):283-7. PubMed ID: 9621132 [Abstract] [Full Text] [Related]
50. Mycosis Fungoides and Sézary Syndrome: An Update. Larocca C, Kupper T. Hematol Oncol Clin North Am; 2019 Feb 01; 33(1):103-120. PubMed ID: 30497668 [Abstract] [Full Text] [Related]
51. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome. Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Best Pract Res Clin Haematol; 2019 Sep 01; 32(3):239-252. PubMed ID: 31585624 [Abstract] [Full Text] [Related]
52. Helper T cell and antibody responses to infection of CBA mice with Babesia microti. Chen D, Copeman DB, Burnell J, Hutchinson GW. Parasite Immunol; 2000 Feb 01; 22(2):81-8. PubMed ID: 10652120 [Abstract] [Full Text] [Related]
53. Sézary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). Dummer R, Geertsen R, Ludwig E, Niederer E, Burg G. Leuk Lymphoma; 1998 Feb 01; 28(5-6):515-22. PubMed ID: 9613981 [Abstract] [Full Text] [Related]
54. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome. Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD. J Invest Dermatol; 2009 Dec 01; 129(12):2875-85. PubMed ID: 19626037 [Abstract] [Full Text] [Related]
55. Identification of cytokine and adhesion molecule mRNA in murine lung tissue and isolated T cells and eosinophils by semi-quantitative reverse transcriptase-polymerase chain reaction. Krzesicki RF, Winterrowd GE, Brashler JR, Hatfield CA, Griffin RL, Fidler SF, Kolbasa KP, Shull KL, Richards IM, Chin JE. Am J Respir Cell Mol Biol; 1997 Jun 01; 16(6):693-701. PubMed ID: 9191471 [Abstract] [Full Text] [Related]
56. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome. Kamarashev J, Burg G, Kempf W, Hess Schmid M, Dummer R. J Cutan Pathol; 1998 Sep 01; 25(8):407-12. PubMed ID: 9826165 [Abstract] [Full Text] [Related]
57. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JM. Clin Diagn Lab Immunol; 1999 Jan 01; 6(1):79-84. PubMed ID: 9874668 [Abstract] [Full Text] [Related]
58. Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome. Lemchak D, Banerjee S, Digambar SS, Hood BL, Conrads TP, Jedrych J, Geskin L, Akilov OE. Exp Dermatol; 2018 Feb 01; 27(2):188-190. PubMed ID: 29205518 [Abstract] [Full Text] [Related]
59. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Rico MJ, Benning C, Weingart ES, Streilein RD, Hall RP. Br J Dermatol; 1999 Jun 01; 140(6):1079-86. PubMed ID: 10354074 [Abstract] [Full Text] [Related]
60. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. Sentis HJ, Willemze R, Scheffer E. J Am Acad Dermatol; 1986 Dec 01; 15(6):1217-26. PubMed ID: 2948972 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]